ipl-logo

QUALCOMM, Inc.: Financial Analysis

1115 Words5 Pages

I like to keep my viewers updated with the latest news on stocks that I considered undervalued or worthy to be watched! You can check out all of my recent buys/sells and stock considerations at my site which can be found in my profile. I like to use the CCC spreadsheet which is run and maintained by Dave Fish. When looking at the spreadsheet I like to add my own data filters. This helps me find companies that meet my set of criteria. After the filters were added, I now had a list of companies that I can start researching. This is how I came up with the three stocks listed today. QUALCOMM, Inc. (QCOM) Qualcomm is a semiconductor and telecommunications equipment company that primarily focuses on manufacturing components for mobile devices. …show more content…

I am considering OHI as a buy because of the amazing dividend yield, and the fact that this company has been raising dividends for over 20 straight quarters. OHI has a dividend yield of 8.24% with a 5-year dividend growth rate of 8.8%. This means that OHI has a Chowder Rule of 17.04. (Chowder Rule is when you add the current dividend with the 5-year dividend growth rate). Normally for REIT you would like a Chowder Rule of 8 or higher, but OHI is giving you 17.04 WOW! The 5-year dividend yield average is 6.5%. So you can buy OHI over 174 basis points compared to the 5-year average. Now "Can OHI continue to pay this dividend?" The answer is yes, OHI can. When analyzing REIT, you must look at Funds From Operation ((FFO)) instead of Earning Per Shares …show more content…

is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health ((IH)) and Pfizer Essential Health ((EH)). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development ((R&D)) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra." Source: Google.com I am considering buying shares of PFE because I want to diversify and add more companies in the health sectors into my portfolio. I also find the company to be fair to undervalue right now. Let's talk about the current dividend yield state. PFE dividend yield is at a nice level of 3.89%. The 5-year dividend yield average is 3.4%. You do not get that big basis point jump like QCOM and OHI, but PFE yield is higher than the 5-year average as well as the broader market. Back to the same question as the

Show More
Related
1214 Words | 5 Pages

The Home Depot has paid a dividend each quarter since the 1990’s, raising dividends on every fourth occasion. They even continued to roll out dividends during the financial crisis in 2008 and 2009. For a company so dependent on the housing market this is extremely impressive, and speaks volumes about financial strength. Management currently promises on returning 50% of earning each year through quarterly dividends. They are also committed to reducing share count.

Read More
777 Words | 4 Pages

This information gives the stakeholders an in-depth breakdown of the financials for Verizon. This will show investors and shareholders that they could benefit from doing business with Verizon. Suppliers can see that their will be continual business opportunity with Verizon because they are continuing to

Read More
736 Words | 3 Pages

The company is doing well and growing, but it might not be the best time to invest currently after seeing the ratios and growth from year to year. With the ratios not being astounding Duke Energy will probably not have much gain. Furthermore, the year to year analysis shows that the company is peaking now, so stock prices are higher and unlikely to increase by much. The best time to buy would have been in

Read More
670 Words | 3 Pages

PharmaSIM- Marketing Plan MKTG 613: MARKETING MANAGEMENT Professor Suresh Ramanathan TEAM GAMMA SEVEN Britton Eastburn Temitope Kayode-Ojo Brian Newbury Harsha Srinivasan Introduction: The ALLSTAR brand is one of the leading manufacturers of packaged goods in the world. The company was started in 1924 and it now consists of a consumer product, an international and a pharmaceutical division. The pharmaceutical division of the company produces and markets ethical and OTC medicine.

Read More
888 Words | 4 Pages

This is a huge opportunity which is the combination of private and government backing. Also, FNMA and combination with Freddie Mac control about 90% of the nations secondary mortgage market with gave the company a strong outlook. Another strength FNAM has is the strong relationships with primary market lenders with give the company a front door step when it comes to investment opportunities. Weaknesses

Read More
984 Words | 4 Pages

Their current ratio is 1.4% (total current assets/total current liabilities). According to the Risk Management Association of Financial Ratio Benchmarks, the current average ratio is 1.5%. In 2014, the current ratio for the firm was 1.46% while the average ratio in the industry (NAICS 311330) was 1.6%. The company’s net property and equipment in 2015 is worth 2.6 million dollars, a slight increase from 2014, which was 2.3 million. The company is considering taking on some debt to increase their production capabilities.

Read More
1939 Words | 8 Pages

Although, the FCF at the beginning of this phase was negative, it was made up over the remainder of phase 3. This phase resulted in an additional value creation of $715,000, but also resulted in a cash surplus of $740,000 at the end of 2021. This may be seen as a failure to invest by some investors, but it also provides SNC with extra cash to pay its liabilities or invest more in a future project. SNC could also use its additional funds to pay a dividend to its shareholders, which has not previously been done before. The introduction of a dividend could help appease investors who are

Read More
1341 Words | 6 Pages

This means that every dollar of current liabilities is backed by just over $2.50 worth of current assets, which is a positive for any business. Gemini’s Quick Ratio has barely changed

Read More
349 Words | 2 Pages

Both companies achieved a market share price increase of 84%. Fairfax had an increase on dividends paid per share which when reflected with its increased share price brings it on par with the previous year. APN paid no dividend. 9. Investment recommendations

Read More
825 Words | 4 Pages

The goal is to make a lifechanging medication at an affordable price. Also, owning a lot of patents under their name has helped them earn a lot of profits. The Merck company has succeeded in differentiating itself as cost leadership

Read More
921 Words | 4 Pages

Cost of equity was calculated using the 10 year UST rate, 5.02%, because it is a good measurement of the risk free rate, plus the firm’s beta, 0.56, multiplied by the risk premium, which we concluded to be 5%. This gave Blaine, when unlevered, a WACC of 7.82%. When taking the $40 million debt and $100 million cash buyout of stocks into account, cost of debt is now a factor. Cost of debt was 5.88%, the bond rating of a AAA rated company like we assume Blaine

Read More
846 Words | 4 Pages

e. (2) Another method for estimating growth rate: Another method for estimating the growth rate is to use the retention growth model: g = (1 - Payout Ratio) ROE In This is consistent with the 5% rate given earlier. e. (3) DCF method could be applied if the growth rate were not

Read More
1472 Words | 6 Pages

There is large investments being made in new technology to reduce production times and improve quality so that patients receive the best quality products in the swiftest manner. Patient care is at the heart of Janssen as clinical trials are on site to always try to gain more information on the potential products to improve. Janssen is a subsidiary of Johnson & Johnson, so to look at the organisation structure it must fall under J&J’s structure first. J&J’s organisation can be split into three main factions; Consumer healthcare, medical devices and pharmaceuticals.

Read More
985 Words | 4 Pages

Low valuation ratios of these two companies indicated that their stock price might not be

Read More
720 Words | 3 Pages

Many new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the

Read More

More about QUALCOMM, Inc.: Financial Analysis

Related Topics

Open Document